Model nutraceuticals and systemic inflammation

Inflammation is the body's defensive response to an attack, whether it be an infection or an injury. Acute inflammation is a rapid, short-lived reaction aimed at eliminating the attacking agent and repairing tissue. Managing inflammation is essential to preventing complications and improving patients' quality of life.
 

Background of Model nutraceuticals and systemic inflammation 

Nutraceuticals are gaining significant attention for their potential role in managing systemic inflammation. Their potential anti-inflammatory effects are typically linked to antioxidant effects and/or immunomodulation. Research has highlighted several nutraceuticals with strong evidence for modulating systemic inflammation : Curcumin, Omega-3 Fatty Acids, Ginger or Polyphenols.

At Vibiosphen, we provide a robust model of systemic inflammation to support the development of novel nutraceuticals. Our model is designed to generate clinically relevant data that help pharmaceutical, and biotechnology companies accelerate food supplement discovery.

 

Mouse Model nutraceuticals and systemic inflammation

• The primary mouse lineages used in preclinical studies are inbred strains known for their genetic uniformity, which minimizes experimental variability.
  • C57BL/6 mice 
  • BALB/c mice
• Outbred mice, unlike their inbred counterparts, are maintained in large, randomly bred colonies to maximize genetic variation. This heterogeneity makes each mouse genetically unique.
  • CD-1 (also known as ICR) mice
  • Swiss mice
  •  

 Model design of the model of systemic inflammation

Outcome of the model of systemic inflammation 

Why Choose Vibiosphen?

• Proven expertise in infectious disease research
• Flexible and customized study designs adapted to sponsor requirements (see downloads available as example) 
• Advanced facilities to ensure reliable and reproducible results (BSL2 and BSL3) 
• Strong collaborations with pharmaceutical companies, biotech firms, and academic partners

Vibiosphen combines scientific excellence with industry know-how to deliver actionable preclinical data that drive innovation in infectious disease therapeutics.

Contact Us

If you are developing new treatments or vaccines against pulmonary infections, Vibiosphen can help accelerate your research.

Contact us today to discuss your project and explore how our pulmonary infection models can support your development strategy. 

We will be pleased to facilitate your project by providing a customized study design to your project objectives.